WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.

MLA

Wang, Xiang, et al. “WP1130 Attenuates Cisplatin Resistance by Decreasing P53 Expression in Non-Small Cell Lung Carcinomas.” Oncotarget, vol. 8, no. 30, July 2017, pp. 49033–43. EBSCOhost, https://doi.org/10.18632/oncotarget.16931.

APA

Wang, X., Bao, Y., Dong, Z., Chen, Q., Guo, H., Ziang, C., & Shao, J. (2017). WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas. Oncotarget, 8(30), 49033–49043. https://doi.org/10.18632/oncotarget.16931

Chicago

Wang, Xiang, Ying Bao, Zhaohui Dong, Qiuqiang Chen, Huihui Guo, Charlie Ziang, and Jianzhong Shao. 2017. “WP1130 Attenuates Cisplatin Resistance by Decreasing P53 Expression in Non-Small Cell Lung Carcinomas.” Oncotarget 8 (30): 49033–43. doi:10.18632/oncotarget.16931.